Qinghua Mao
Inventor
Stats
- 6 US patents issued
- 13 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 6 US Patents Issued
- 13 US Applications Filed
- 8 Total Citation Count
- Aug 24, 2022 Most Recent Filing
- Sep 17, 2014 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| MERCK SHARP & DOHMECORP. | 2
| 2015
|
| WUXI APP TEC (SHANGHAI) CO., LTD. | 2
| 2015
|
| MERCK SHARP & DOHME CORP. | 4
8 | 2014
2015 |
| MSD R&D (CHINA) CO., LTD. | 2
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| SHANGHAI, CN | Oct 22, 20 - Oct 22, 20 |
| Shanghai, CN | Aug 11, 16 - Mar 25, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
| C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 12258367 | 2025 | Glucoside derivative that acts as SGLT1 inhibitor and application thereof | 0 |
| 2024/0368,178 | 2024 | IMIDAZOCYCLIC COMPOUND AND APPLICATION THEREOF | 0 |
| 2022/0324,897 | 2022 | CRYSTAL FORM OF SGLT INHIBITOR AND APPLICATION THEREOF | 0 |
| 2022/0259,247 | 2022 | SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF | 0 |
| 2022/0242,898 | 2022 | SGLT2/DPP4 INHIBITOR AND APPLICATION THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.